Biostage, Inc.
(Other OTC/NBB : HART)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.57%201.951.2%$404.38m
GILDGilead Sciences, Inc.
-0.03%72.760.9%$394.36m
CELGCelgene Corporation
0.41%87.561.2%$340.53m
BIIBBiogen Inc.
0.22%335.141.2%$274.57m
ILMNIllumina, Inc.
1.39%352.063.5%$255.76m
REGNRegeneron Pharmaceuticals, Inc.
-1.08%382.302.6%$207.96m
EXASExact Sciences Corporation
-0.93%72.6525.3%$196.84m
VRTXVertex Pharmaceuticals Incorporated
0.22%176.191.9%$160.23m
SRPTSarepta Therapeutics, Inc.
0.00%152.3616.4%$124.88m
AAgilent Technologies, Inc.
-0.65%68.631.5%$120.70m
ALXNAlexion Pharmaceuticals, Inc.
1.12%119.132.0%$108.70m
NKTRNektar Therapeutics
0.86%58.815.6%$96.79m
ALNYAlnylam Pharmaceuticals, Inc
-0.08%93.289.7%$95.74m
BMRNBioMarin Pharmaceutical Inc.
0.71%98.854.4%$91.33m
INCYIncyte Corporation
0.60%67.422.5%$88.23m

Company Profile

Biostage, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. The company was founded on May 3, 2012 and is headquartered in Holliston, MA.